Glucocorticoids influence on rat hematological parameters and catalase activity

Area of Science:

• Biochemistry and Pharmacology
• Hematology and Toxicology

Background:

• Catalase is vital for cellular defense against oxidative stress by reducing hydrogen peroxide.
• Glucocorticoids, like betamethasone dipropionate, are widely used for their anti-inflammatory properties but can have systemic effects.
• Understanding the precise biochemical and physiological impacts of betamethasone dipropionate is crucial for safe clinical application.

Purpose of the Study:

• To investigate the in vitro effects of betamethasone dipropionate on immobilized catalase activity.
• To evaluate the in vivo impact of betamethasone dipropionate on hematological parameters in rats.
• To elucidate the inhibition kinetics and systemic consequences of betamethasone dipropionate administration.

Main Methods:

• In vitro enzyme kinetics of immobilized catalase using electrocatalytic methods and Lineweaver-Burke analysis.
• Administration of betamethasone dipropionate to Rattus norvegicus (rats).
• Analysis of hematological parameters including erythrocyte count, hemoglobin, MCV, MCH, MCHC, and leukocyte count.

Main Results:

• Betamethasone dipropionate demonstrated uncompetitive inhibition of catalase in vitro, altering Vmax and Km.
• In vivo administration led to decreased erythrocyte count, increased hemoglobin, reduced MCV, and elevated MCH and MCHC.
• Significant increase in leukocyte counts was observed, suggesting a pronounced impact on the hematopoietic system.

Conclusions:

• Betamethasone dipropionate exerts both direct enzymatic inhibitory effects and systemic hematological alterations.
• The observed changes in hematological parameters highlight potential risks associated with corticosteroid therapy.
• Judicious use of corticosteroids is warranted, considering their enzymatic and systemic repercussions.